探索尼泊尔药学教育课程差距:试点研究和改革建议
Tara Man Kadayat1, Niraj Sharma2, Amrit Gaire3
1College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA; College of Pharmacy, Larkin University, Miami, FL 33169, USA.
Currents in pharmacy teaching & learning
|February 21, 2026
概括
尼泊尔的药房教育面临重大挑战,包括理论与实践之间的差距和教师问题. 需要进行改革,以加强药学毕业生的临床培训和专业准备.
科学领域:
- 药房 教育 教育 药房 教育
- 在尼泊尔的高等教育.
- 健康 职业 教育 教育 专业
背景情况:
- 尼泊尔的药房教育正在审查其当前状态和有效性.
- 确定的问题包括理论知识和实际应用之间的差距,以及教师专业知识的挑战.
- 在药学毕业生中提高专业准备的需要是一个越来越令人担忧的问题.
研究的目的:
- 调查尼泊尔目前药学教育中的现状,挑战和问题.
- 确定需要改进的领域,并提供可行的建议.
- 为未来的药房培训计划改革提供信息.
主要方法:
- 焦点小组讨论通过Zoom与利益相关者在线进行.
- 参与者包括四所尼泊尔药学院的药学学士 (BPharm) 学生,教师和校友.
- 采用主题分析,从定性数据中确定关键主题.
主要成果:
- 六个主要主题出现了:理论与实践之间的差距,实习效率低下,教师专业知识不匹配,教学方法不足,专业身份薄弱和资源限制.
- 参与者强调了课程改革和改善实践培训的必要性.
- 参与者提供了加强药房教育的建议.
结论:
- 为尼泊尔药学教育提出了变革性改革,可能是通过重组BPharm计划或采用药学博士 (PharmD) 模式.
- 主要建议包括加强体验式学习,创新教学,专业身份,监管框架,课程开发和资源优化.
- 这些变化旨在提高临床技能,并确保毕业生有专业准备.
相关概念视频
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
302
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
30
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
30
01:03Drug Control Governance: Regulatory Bodies and Their Impact
612
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
612
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
198
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
198
01:22Nonlinear Pharmacokinetics: Causes of Nonlinearity
782
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
782